147 related articles for article (PubMed ID: 28290017)
1. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: Preparation and characterization.
Lai F; Wissing SA; Müller RH; Fadda AM
AAPS PharmSciTech; 2006 Mar; 7(1):E10. PubMed ID: 28290017
[TBL] [Abstract][Full Text] [Related]
2. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: preparation and characterization.
Lai F; Wissing SA; Müller RH; Fadda AM
AAPS PharmSciTech; 2006 Jan; 7(1):E2. PubMed ID: 16584150
[TBL] [Abstract][Full Text] [Related]
3. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study.
Lai F; Sinico C; De Logu A; Zaru M; Müller RH; Fadda AM
Int J Nanomedicine; 2007; 2(3):419-25. PubMed ID: 18019840
[TBL] [Abstract][Full Text] [Related]
4. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.
Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP
Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540
[TBL] [Abstract][Full Text] [Related]
10. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
Silva AC; González-Mira E; García ML; Egea MA; Fonseca J; Silva R; Santos D; Souto EB; Ferreira D
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):158-65. PubMed ID: 21530187
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity.
Fazly Bazzaz BS; Khameneh B; Namazi N; Iranshahi M; Davoodi D; Golmohammadzadeh S
Lett Appl Microbiol; 2018 Jun; 66(6):506-513. PubMed ID: 29569372
[TBL] [Abstract][Full Text] [Related]
13. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
Venkateswarlu V; Manjunath K
J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
[TBL] [Abstract][Full Text] [Related]
15. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
16. [Microstructure of novel solid lipid nanoparticle loaded triptolide].
Hou DZ; Xie CS; Yang XL; Xu HB; Ping QN
Yao Xue Xue Bao; 2007 Apr; 42(4):429-33. PubMed ID: 17633214
[TBL] [Abstract][Full Text] [Related]
17. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants.
Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J
Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository.
Mohamed RA; Abass HA; Attia MA; Heikal OA
J Pharm Pharmacol; 2013 Nov; 65(11):1607-21. PubMed ID: 24102470
[TBL] [Abstract][Full Text] [Related]
19. Preparation of solid lipid nanoparticles loaded with garlic oil and evaluation of their in vitro and in vivo characteristics.
Wencui Z; Qi Z; Ying W; Di W
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3742-50. PubMed ID: 26502865
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
